Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

SIU-ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer.

Leow JJ, Bedke J, Chamie K, Collins JW, Daneshmand S, Grivas P, Heidenreich A, Messing EM, Royce TJ, Sankin AI, Schoenberg MP, Shipley WU, Villers A, Efstathiou JA, Bellmunt J, Stenzl A.

World J Urol. 2019 Jan;37(1):61-83. doi: 10.1007/s00345-018-2606-y. Epub 2019 Jan 25. Review.

PMID:
30684034
2.

Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation.

Mitra AP, Fairey AS, Skinner EC, Boorjian SA, Frank I, Schoenberg MP, Bivalacqua TJ, Hyndman ME, Reese AC, Steinberg GD, Large MC, Hulsbergen-van de Kaa CA, Bruins HM, Daneshmand S.

Urol Oncol. 2019 Jan;37(1):48-56. doi: 10.1016/j.urolonc.2018.10.013. Epub 2018 Nov 13.

PMID:
30446450
3.

Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder Cancer.

Milbar N, Kates M, Chappidi MR, Pederzoli F, Yoshida T, Sankin A, Pierorazio PM, Schoenberg MP, Bivalacqua TJ.

Bladder Cancer. 2017 Oct 27;3(4):293-303. doi: 10.3233/BLC-170126.

4.

Hospital Charges and Length of Stay Following Radical Cystectomy in the Enhanced Recovery After Surgery Era.

Semerjian A, Milbar N, Kates M, Gorin MA, Patel HD, Chalfin HJ, Frank SM, Wu CL, Yang WW, Hobson D, Robertson L, Wick E, Schoenberg MP, Pierorazio PM, Johnson MH, Stimson CJ, Bivalacqua TJ.

Urology. 2018 Jan;111:86-91. doi: 10.1016/j.urology.2017.09.010. Epub 2017 Oct 13.

PMID:
29032237
5.

The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3.

Janakiram M, Shah UA, Liu W, Zhao A, Schoenberg MP, Zang X.

Immunol Rev. 2017 Mar;276(1):26-39. doi: 10.1111/imr.12521. Review.

6.

Biomanufacturing Seamless Tubular and Hollow Collagen Scaffolds with Unique Design Features and Biomechanical Properties.

Singh A, Lee D, Sopko N, Matsui H, Sabnekar P, Liu X, Elisseeff J, Schoenberg MP, Pienta K, Bivalacqua TJ.

Adv Healthc Mater. 2017 Mar;6(5). doi: 10.1002/adhm.201601136. Epub 2017 Jan 30.

PMID:
28135047
7.

A review of the PD-1/PD-L1 checkpoint in bladder cancer: From mediator of immune escape to target for treatment.

Zhou TC, Sankin AI, Porcelli SA, Perlin DS, Schoenberg MP, Zang X.

Urol Oncol. 2017 Jan;35(1):14-20. doi: 10.1016/j.urolonc.2016.10.004. Epub 2016 Nov 3. Review.

PMID:
27816403
8.

Microhematuria assessment an IBCN consensus-Based upon a critical review of current guidelines.

Schmitz-Dräger BJ, Kuckuck EC, Zuiverloon TC, Zwarthoff EC, Saltzman A, Srivastava A, Hudson MA, Seiler R, Todenhöfer T, Vlahou A, Grossman HB, Schoenberg MP, Sanchez-Carbayo M, Brünn LA, van Rhijn BW, Goebell PJ, Kamat AM, Roupret M, Shariat SF, Kiemeney LA.

Urol Oncol. 2016 Oct;34(10):437-51. doi: 10.1016/j.urolonc.2016.05.030. Epub 2016 Sep 15. Review.

PMID:
27641313
9.

Vesigenurtacel-L (HS-410) in the management of high-grade nonmuscle invasive bladder cancer.

Keehn A, Gartrell B, Schoenberg MP.

Future Oncol. 2016 Dec;12(23):2673-2682. Epub 2016 Sep 9. Review.

PMID:
27609194
10.

Infectious complications in transfused patients after radical cystectomy.

Liu JJ, Mullane P, Kates M, Gandhi N, Schoenberg MP, Drake C, Hahn NM, Frank S, Bivalacqua TJ.

Can J Urol. 2016 Aug;23(4):8342-7.

PMID:
27544556
11.

The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder.

Baras AS, Drake C, Liu JJ, Gandhi N, Kates M, Hoque MO, Meeker A, Hahn N, Taube JM, Schoenberg MP, Netto G, Bivalacqua TJ.

Oncoimmunology. 2016 Feb 18;5(5):e1134412. doi: 10.1080/2162402X.2015.1134412. eCollection 2016 May.

12.

Accuracy of urethral frozen section during radical cystectomy for bladder cancer.

Kates M, Ball MW, Chappidi MR, Baras AS, Gordetsky J, Sopko NA, Brant A, Pierorazio PM, Epstein JI, Schoenberg MP, Bivalacqua TJ.

Urol Oncol. 2016 Dec;34(12):532.e1-532.e6. doi: 10.1016/j.urolonc.2016.06.014. Epub 2016 Jul 16.

PMID:
27432433
14.

Blood Transfusion is Associated with Increased Perioperative Morbidity and Adverse Oncologic Outcomes in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy and Radical Cystectomy.

Chalfin HJ, Liu JJ, Gandhi N, Feng Z, Johnson D, Netto GJ, Drake CG, Hahn NM, Schoenberg MP, Trock BJ, Scott AV, Frank SM, Bivalacqua TJ.

Ann Surg Oncol. 2016 Aug;23(8):2715-22. doi: 10.1245/s10434-016-5193-4. Epub 2016 Mar 24.

PMID:
27012987
15.

Clarification of Bladder Cancer Disease States Following Treatment of Patients with Intravesical BCG.

Lerner SP, Dinney C, Kamat A, Bivalacqua TJ, Nielsen M, O'Donnell M, Schoenberg MP, Steinberg G.

Bladder Cancer. 2015 Mar 30;1(1):29-30. No abstract available.

16.

A Retrospective Analysis of the Effect on Survival of Time from Diagnosis to Neoadjuvant Chemotherapy to Cystectomy for Muscle Invasive Bladder Cancer.

Park JC, Gandhi NM, Carducci MA, Eisenberger MA, Baras AS, Netto GJ, Liu JJ, Drake CG, Schoenberg MP, Bivalacqua TJ, Hahn NM.

J Urol. 2016 Apr;195(4 Pt 1):880-5. doi: 10.1016/j.juro.2015.11.024. Epub 2015 Nov 18.

PMID:
26598426
17.

Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder.

Reis LO, Taheri D, Chaux A, Guner G, Mendoza Rodriguez MA, Bivalacqua TJ, Schoenberg MP, Epstein JI, Netto GJ.

Hum Pathol. 2016 Jan;47(1):20-5. doi: 10.1016/j.humpath.2015.09.007. Epub 2015 Sep 25.

PMID:
26520419
18.

Multimodal Therapy in the Treatment of Prostate Sarcoma: The Johns Hopkins Experience.

Ball MW, Sundi D, Reese AC, Meyer CF, Terezakis SA, Efron JE, Schoenberg MP, Epstein JI, Ahuja N, Bivalacqua TJ.

Clin Genitourin Cancer. 2015 Oct;13(5):435-40. doi: 10.1016/j.clgc.2015.04.011. Epub 2015 May 2.

PMID:
26003268
19.

Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes.

Gandhi NM, Baras A, Munari E, Faraj S, Reis LO, Liu JJ, Kates M, Hoque MO, Berman D, Hahn NM, Eisenberger M, Netto GJ, Schoenberg MP, Bivalacqua TJ.

Urol Oncol. 2015 May;33(5):204.e1-7. doi: 10.1016/j.urolonc.2015.02.011. Epub 2015 Mar 23.

20.

Tissue-engineered urinary conduits.

Kates M, Singh A, Matsui H, Steinberg GD, Smith ND, Schoenberg MP, Bivalacqua TJ.

Curr Urol Rep. 2015 Mar;16(3):8. doi: 10.1007/s11934-015-0480-3. Review.

PMID:
25677229
21.

Extent of pelvic lymph node dissection during radical cystectomy: is bigger better?

Sundi D, Svatek RS, Nielsen ME, Schoenberg MP, Bivalacqua TJ.

Rev Urol. 2014;16(4):159-66. Review.

22.

Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA.

Daneshmand S, Schuckman AK, Bochner BH, Cookson MS, Downs TM, Gomella LG, Grossman HB, Kamat AM, Konety BR, Lee CT, Pohar KS, Pruthi RS, Resnick MJ, Smith ND, Witjes JA, Schoenberg MP, Steinberg GD.

Nat Rev Urol. 2014 Oct;11(10):589-96. doi: 10.1038/nrurol.2014.245. Epub 2014 Sep 23. Review.

PMID:
25245244
23.

ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladder.

Faraj SF, Chaux A, Gonzalez-Roibon N, Munari E, Ellis C, Driscoll T, Schoenberg MP, Bivalacqua TJ, Shih IeM, Netto GJ.

Hum Pathol. 2014 Nov;45(11):2233-9. doi: 10.1016/j.humpath.2014.07.003. Epub 2014 Jul 23.

PMID:
25175170
24.

Reply: To PMID 25065987.

Reese AC, Bivalacqua TJ, Schoenberg MP.

Urology. 2014 Aug;84(2):364. doi: 10.1016/j.urology.2014.03.045. No abstract available.

PMID:
25065989
25.

The utility of an extensive postchemotherapy staging evaluation in patients receiving neoadjuvant chemotherapy for bladder cancer.

Reese AC, Ball MW, Gandhi N, Gorin MA, Netto GJ, Bivalacqua TJ, Schoenberg MP.

Urology. 2014 Aug;84(2):358-63. doi: 10.1016/j.urology.2014.03.040.

26.

Impact of hospital volume on perioperative outcomes and costs of radical cystectomy: analysis of the Maryland Health Services Cost Review Commission database.

Gorin MA, Kates M, Mullins JK, Pierorazio PM, Matlaga BR, Schoenberg MP, Bivalacqua TJ.

Can J Urol. 2014 Feb;21(1):7102-7.

PMID:
24529009
27.

In-hospital death and hospital-acquired complications among patients undergoing partial cystectomy for bladder cancer in the United States.

Kates M, Gorin MA, Deibert CM, Pierorazio PM, Schoenberg MP, McKiernan JM, Bivalacqua TJ.

Urol Oncol. 2014 Jan;32(1):53.e9-14. doi: 10.1016/j.urolonc.2013.08.024. Epub 2013 Nov 13.

PMID:
24239467
28.

Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.

Tilki D, Shariat SF, Lotan Y, Rink M, Karakiewicz PI, Schoenberg MP, Lerner SP, Sonpavde G, Sagalowsky AI, Gupta A.

BJU Int. 2013 Jun;111(8):1215-21. doi: 10.1111/j.1464-410X.2012.11455.x. Epub 2012 Nov 26.

29.

The use of regenerative medicine in the management of invasive bladder cancer.

Hyndman ME, Kaye D, Field NC, Lawson KA, Smith ND, Steinberg GD, Schoenberg MP, Bivalacqua TJ.

Adv Urol. 2012;2012:653652. Epub 2012 Aug 27.

30.

ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder.

Gakis G, Efstathiou J, Lerner SP, Cookson MS, Keegan KA, Guru KA, Shipley WU, Heidenreich A, Schoenberg MP, Sagaloswky AI, Soloway MS, Stenzl A; International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012.

Eur Urol. 2013 Jan;63(1):45-57. doi: 10.1016/j.eururo.2012.08.009. Epub 2012 Aug 14. Review.

PMID:
22917985
31.

High epidermal growth factor receptor immunohistochemical expression in urothelial carcinoma of the bladder is not associated with EGFR mutations in exons 19 and 21: a study using formalin-fixed, paraffin-embedded archival tissues.

Chaux A, Cohen JS, Schultz L, Albadine R, Jadallah S, Murphy KM, Sharma R, Schoenberg MP, Netto GJ.

Hum Pathol. 2012 Oct;43(10):1590-5. doi: 10.1016/j.humpath.2011.11.016. Epub 2012 Mar 9.

32.

Ureteral stents placed at the time of urinary diversion decreases postoperative morbidity.

Mullins JK, Guzzo TJ, Ball MW, Pierorazio PM, Eifler J, Jarrett TW, Schoenberg MP, Bivalacqua TJ.

Urol Int. 2012;88(1):66-70. doi: 10.1159/000335212. Epub 2012 Jan 4.

33.

Smoking knowledge assessment and cessation trends in patients with bladder cancer presenting to a tertiary referral center.

Guzzo TJ, Hockenberry MS, Mucksavage P, Bivalacqua TJ, Schoenberg MP.

Urology. 2012 Jan;79(1):166-71. doi: 10.1016/j.urology.2011.06.055. Epub 2011 Oct 26.

PMID:
22030373
34.

Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder.

Kassouf W, Svatek RS, Shariat SF, Novara G, Lerner SP, Fradet Y, Bastian PJ, Aprikian A, Karakiewicz PI, Fritsche HM, Dinney CP, Tilki D, Kamat AM, Izawa JI, Ficarra V, Lotan Y, Sagalowsky AI, Schoenberg MP, Skinner EC.

Urol Oncol. 2013 May;31(4):480-6. doi: 10.1016/j.urolonc.2011.02.011. Epub 2011 Apr 8.

PMID:
21478035
35.

Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder.

Wang H, Albadine R, Magheli A, Guzzo TJ, Ball MW, Hinz S, Schoenberg MP, Netto GJ, Gonzalgo ML.

Urol Oncol. 2012 Jul-Aug;30(4):428-33. doi: 10.1016/j.urolonc.2010.09.005. Epub 2011 Mar 10.

PMID:
21396836
36.

Is prostate-specific antigen surveillance necessary in men with benign prostate pathology following radical cystoprostatectomy for bladder cancer?

Bivalacqua TJ, Loeb S, Pierorazio PM, Schoenberg MP, Partin AW, Guzzo TJ.

Urol Int. 2010;85(4):466-9. doi: 10.1159/000321693. Epub 2010 Nov 13.

PMID:
21071926
37.

The effectiveness of off-protocol adjuvant chemotherapy for patients with urothelial carcinoma of the urinary bladder.

Svatek RS, Shariat SF, Lasky RE, Skinner EC, Novara G, Lerner SP, Fradet Y, Bastian PJ, Kassouf W, Karakiewicz PI, Fritsche HM, Müller SC, Izawa JI, Ficarra V, Sagalowsky AI, Schoenberg MP, Siefker-Radtke AO, Millikan RE, Dinney CP.

Clin Cancer Res. 2010 Sep 1;16(17):4461-7. doi: 10.1158/1078-0432.CCR-10-0457. Epub 2010 Jul 22.

38.

International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy.

Shariat SF, Svatek RS, Tilki D, Skinner E, Karakiewicz PI, Capitanio U, Bastian PJ, Volkmer BG, Kassouf W, Novara G, Fritsche HM, Izawa JI, Ficarra V, Lerner SP, Sagalowsky AI, Schoenberg MP, Kamat AM, Dinney CP, Lotan Y, Marberger MJ, Fradet Y.

BJU Int. 2010 May;105(10):1402-12. doi: 10.1111/j.1464-410X.2010.09217.x. Epub 2010 Feb 2.

39.

Clinical epidemiology of nonurothelial bladder cancer: analysis of the Netherlands Cancer Registry.

Ploeg M, Aben KK, Hulsbergen-van de Kaa CA, Schoenberg MP, Witjes JA, Kiemeney LA.

J Urol. 2010 Mar;183(3):915-20. doi: 10.1016/j.juro.2009.11.018. Epub 2010 Jan 18.

PMID:
20083267
40.

The presence of circulating tumor cells does not predict extravesical disease in bladder cancer patients prior to radical cystectomy.

Guzzo TJ, McNeil BK, Bivalacqua TJ, Elliott DJ, Sokoll LJ, Schoenberg MP.

Urol Oncol. 2012 Jan-Feb;30(1):44-8. doi: 10.1016/j.urolonc.2009.10.008. Epub 2009 Dec 16.

PMID:
20005748
41.

Pathological upstaging during radical cystectomy is associated with worse recurrence-free survival in patients with bacillus Calmette-Guerin-refractory bladder cancer.

Guzzo TJ, Magheli A, Bivalacqua TJ, Nielsen ME, Attenello FJ, Schoenberg MP, Gonzalgo ML.

Urology. 2009 Dec;74(6):1276-80. doi: 10.1016/j.urology.2009.05.092. Epub 2009 Sep 16.

PMID:
19758684
42.

Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer.

Isbarn H, Karakiewicz PI, Shariat SF, Capitanio U, Palapattu GS, Sagalowsky AI, Lotan Y, Schoenberg MP, Amiel GE, Lerner SP, Sonpavde G.

J Urol. 2009 Aug;182(2):459-65; discussion 465. doi: 10.1016/j.juro.2009.04.017. Epub 2009 Jun 13.

PMID:
19524971
43.

A case of gastrointestinal stromal tumor diagnosed on prostate biopsy.

Loeb S, Lotan TL, Thornton K, Gearhart SL, Schoenberg MP.

Nat Clin Pract Urol. 2009 Jan;6(1):54-7. doi: 10.1038/ncpuro1264. Epub 2008 Dec 2.

PMID:
19048005
44.

Presentation and management of a patient with subcutaneous metastatic transitional cell carcinoma of the bladder.

Alphs HH, Miles-Thomas J, Attenello F, Taube JM, Fonseca G, Guzzo TJ, Schoenberg MP, Bivalacqua TJ.

Nat Clin Pract Urol. 2008 Dec;5(12):691-4. doi: 10.1038/ncpuro1253. Epub 2008 Nov 11.

PMID:
19002126
45.

Outcomes of patients after aborted radical cystectomy for intraoperative findings of metastatic disease.

Guzzo TJ, Rogers CG, Deng CY, Bivalacqua TJ, Palapattu GS, Bastian PJ, Eisenberger MA, Schoenberg MP, Gonzalgo ML.

BJU Int. 2008 Dec;102(11):1539-43. doi: 10.1111/j.1464-410X.2008.07877.x. Epub 2008 Aug 22.

46.

Bladder cancer and the aluminium industry: a review.

Guzzo TJ, Bivalacqua TJ, Schoenberg MP.

BJU Int. 2008 Nov;102(9):1058-60. doi: 10.1111/j.1464-410X.2008.07903.x. Epub 2008 Aug 1. Review. No abstract available.

47.

Prospective intermediate follow-up of carcinoma in situ involving the distal ureter at cystectomy: is there a role for ureteroscopy?

Wagner KR, Schoenberg MP, Bianco FJ Jr, Jarrett TW.

J Endourol. 2008 Jun;22(6):1241-6. doi: 10.1089/end.2008.0074.

PMID:
18578657
48.

Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy.

Gupta A, Lotan Y, Bastian PJ, Palapattu GS, Karakiewicz PI, Raj GV, Schoenberg MP, Lerner SP, Sagalowsky AI, Shariat SF; Bladder Cancer Research Consortium.

Urology. 2008 Feb;71(2):302-7. doi: 10.1016/j.urology.2007.10.041.

PMID:
18308108
49.

Recurrence-free survival after radical cystectomy of patients downstaged by transurethral resection.

Nielsen ME, Bastian PJ, Palapattu GS, Trock BJ, Schoenberg MP, Chan T, Rogers CG.

Urology. 2007 Dec;70(6):1091-5.

PMID:
18158024
50.

Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival.

Bastian PJ, Hutterer GC, Shariat SF, Rogers CG, Palapattu GS, Lotan Y, Vazina A, Amiel GE, Gupta A, Sagalowsky AI, Lerner SP, Schoenberg MP, Karakiewicz PI; Bladder Cancer Research Consortium.

BJU Int. 2008 Feb;101(4):450-4. Epub 2007 Sep 10.

Supplemental Content

Loading ...
Support Center